Connect with us

Medtech

Portfolia Invests in Xandar Kardian for Health Monitoring

What You Should Know: – Portfolia, the world’s most powerful community of women investors, has officially announced a significant investment in Xandar…

Published

on

This article was originally published by HIT Consultant
Portfolia Invests in Xandar Kardian for Health Monitoring

What You Should Know:

Portfolia, the world’s most powerful community of women investors, has officially announced a significant investment in Xandar Kardian from the firm’s Active Aging I and Active Aging II funds. Portfolia’s investment represents a core contribution to Xandar Kardian’s $10 million Series A Funding round.

– Portfolia sees Xandar Kardian’s impact extends well beyond the traditional hospital room, with impressive potential growth opportunities into a wider breadth of long-term care subcategories in the coming years – including assisted living, independent living and active adult living communities.

Digital Automation with Radar Accuracy

Founded in 2017 as a US Delaware C-Corp with international operations spanning South Korea, Canada and the United States, Xandar Kardian is led by CEO and founder Sam Yang with a mission of deploying reliable and high-accuracy cleantech, smart building and healthcare solutions worldwide. Xandar Kardian’s XK300 became the first continuous, autonomous radar-powered health monitoring system to achieve FDA 510(k) clearance as a Class II Medical Device for non-invasive monitoring. The product’s sensors provide critical early deterioration detection in healthcare settings by measuring 6000+ RHR (Resting Heart Rate) & RR (Respiratory Rate) readings a day, as opposed to a traditional hospital setting, where these vital signs are measured manually only 4 to 6 times a day.

The Xandar Kardian XK300 Autonomous Health Monitoring Solution achieved 510(k) Clearance by the U.S. Food & Drug Administration in April 2021, paving the way for a new era of accurate and reliable healthcare technology. With 23 patents granted and 11 pending, Xandar Kardian’s technology has received more than 25 accolades and awards over the last few years – among them being inclusion on TIME’s Best Inventions of 2022, Fast Company’s Most Innovative Companies of 2022, and 11 CES Innovation Awards.

respiratory




device

Medtech

ETF Talk: AI is ‘Big Generator’

Second nature comes alive Even if you close your eyes We exist through this strange device — Yes, “Big Generator” Artificial intelligence (AI) has…

Continue Reading
Medtech

Apple gets an appeals court win for its Apple Watch

Apple has at least a couple more weeks before it has to worry about another sales ban.

Continue Reading
Medtech

Federal court blocks ban on Apple Watches after Apple appeal

A federal appeals court has temporarily blocked a sweeping import ban on Apple’s latest smartwatches while the patent dispute winds its way through…

Continue Reading

Trending